Compare WST & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | LII |
|---|---|---|
| Founded | 1923 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.7B | 17.7B |
| IPO Year | N/A | 1999 |
| Metric | WST | LII |
|---|---|---|
| Price | $236.61 | $506.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | $338.00 | ★ $600.17 |
| AVG Volume (30 Days) | ★ 825.9K | 366.3K |
| Earning Date | 02-12-2026 | 01-28-2026 |
| Dividend Yield | 0.37% | ★ 1.02% |
| EPS Growth | 0.17 | ★ 12.46 |
| EPS | 6.75 | ★ 23.67 |
| Revenue | $3,017,900,000.00 | ★ $5,345,300,000.00 |
| Revenue This Year | $6.97 | N/A |
| Revenue Next Year | $6.27 | $6.38 |
| P/E Ratio | $35.05 | ★ $21.54 |
| Revenue Growth | ★ 4.92 | 3.77 |
| 52 Week Low | $187.43 | $443.19 |
| 52 Week High | $348.90 | $689.44 |
| Indicator | WST | LII |
|---|---|---|
| Relative Strength Index (RSI) | 27.79 | 48.12 |
| Support Level | $244.70 | $500.75 |
| Resistance Level | $258.74 | $522.27 |
| Average True Range (ATR) | 10.77 | 15.61 |
| MACD | -4.09 | -1.70 |
| Stochastic Oscillator | 8.06 | 30.62 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.